provide a link, or be dismissed as just another shorty pumper
Today pullback may be some big money trying to drive it down so they can pick up shares before tomorrow.
PEG of 0.23!? /NG natural gas rocketing UP today, which has the highest correlation with solar competition, This valuation just doesn't make any sense. It's already successfully tested the 25's. China has been vocal about heading off revolution from smog-infuriated citizens by going solar/wind. Anyone got an actual believable reason why this should be down 4% today? I'm tempted to load up.
I'd have thought the stock would be UP today, given the vote of confidence this is a solid, real company by a major global bank, and given the sweetener for warrants exercisable at a price 20% higher than right now. So yeah, this makes no sense to me. Buy more.
Do they go to Utility Scale facilities, or rooftops? If the latter, the SCTY spillover may explain at least the movement - but even then, SCTY is down because they don't have a defendable monopoly on their business model, and they're losing share. So these knee-jerk selloffs are just a buying opportunity. Note that oil is stable, and nat gas is rising today.
neither the buying nor the selling of the past hour had any real volume. Yesterday's announcement of the Nov 4 ER didn't hurt the stock, and I expect a positive ER in any event. This looks like pure market makers toying with a stock they want more of, and has a small float and daily volume so they can whack at it effectively. I bought a bit more today.
Sentiment: Strong Buy
I bought this because of the low risk, new orphan drug designation, and low PE. The low float makes it both an opportunity and a danger. However, it looks like it's just successfully double-bottomed off the 137 level and the points of jrrhenderson662 are excellent. I can't see any reason in the news for why it had a worse day than BIB or the other biotechs in general, other than the low float and someone wanted out. It should bounce back at least to the high 140's.
BMY has made/signed the deal. All FPRX has to do is what they do best - make outstanding therapies. Look at the royalties alone ("double digit") and it makes the current market cap today look small. Yes, 60% is a lot to do in one day, so there'll be profit-takers perhaps going right into the close. Nibble on any pullbacks that result. This will go higher, and it might be too late tomorrow, after Cramer talks about it.
the Market cap is still only $700M, and the deal is far more than this - I think this has a ways more to go. There's some headwind with profit taking by the faithful who held through this annoucement, so maybe scale in. ....
there's 27 million shares outstanding - so we're talking about a dilution of 0.04% !! It's nothing. Stop your ranting. Buy the dip. Shorts are scared of a squeeze - looks like that's you too.
At consensus peak sales of $2B for the Parkinson's market alone (not counting Alz or other future possible sales), ACAD trades at only P/S = 2. That's extremely cheap for biotechs. And with the safety and efficacy profile it has, and the selloff before the announcement into the 30's, this is a strong "buy" right here. Never mind it might go down another half point or so into the close, due to risk-off before China opens again. At least, you should all be nibbling as it edges lower today. The short-bashers out there are just trying to get your shares cheap - don't be a sucker.
thanks. Yes, black humor indeed. Solar-loving congress. Yup. Still, that's 15 months away. SEDG's guidance was pretty strong, and the valuation analysis given in SA made a good case that 32 was quite a reasonable and cheap share price. So it surprises me that buyers aren't coming in down here. I can't believe it's still the knee-jerk low oil means forget solar. Solar panels are quite competitive and prices are still dropping.
Just technicals - It dropped from 25.3 to 22.3 on nothing, that's a 10% drop. I'm guessing it'll at least hit 24 or 24.4 before resuming any downtrend given no news is driving this. I expect it's just a general profit-taking of small biotechs.
heading in to the last hour; expect hyperventilating shorts to start covering. Fell below support today, and that's a reliable place to see a bounce. Look at any stock chart you want and thats what you see more often than not.
I can't figure out why we're still in the 40's. Guidance of $3.50 for the year, vs mid 2's expectation? And the EPS on full year and in AH at a subterranean 14? And with Big Oil losing the climate wars, this should be over 50 easy, and maybe 60 given the future beyond. I've seen this sort of thing before, the clueless retail investors taking their 10% profits and running, while the smart money during the regular hours the next day look at the numbers and price it properly. I'll hang on and wait.
The worry had been that the Alzheimer's conference would have blockbuster news on a cure or major disease-modifying results from these big players. Now that we know the news is .... meh.... that's good for ACAD and it's ongoing trials for symptom relief. We may chop around here in the high 40's low 50's, but they're still a prime company to receive an offer - still a tiny company with a can't miss drug about ready to launch.